---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-021081"
form_type: "8-K"
ticker: "FEMY"
cik: "0001339005"
company_name: "FEMASYS INC"
filed_at: "2026-05-13T20:48:01+00:00"
generated_at: "2026-05-13T21:07:51.249364+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Femasys posts updated investor presentation; no material new disclosures

## Summary
- Slide deck highlights Femasys's reproductive health products and pipeline.
- No financial guidance, earnings, or operational metrics disclosed.
- Presentation available on company website for investor meetings.

## SEC filing metadata
- accession: 0001140361-26-021081
- form_type: 8-K
- ticker: FEMY
- cik: 0001339005
- company_name: FEMASYS INC
- filed_at: 2026-05-13T20:48:01+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1339005/000114036126021081/0001140361-26-021081-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1339005/000114036126021081/ef20073379_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-021081
- JSON: https://secwatch.observer/filing/0001140361-26-021081.json
- Plain text: https://secwatch.observer/filing/0001140361-26-021081.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.